WALTHAM, Mass.--(BUSINESS WIRE)-- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live from the Jefferies 2011 Global Healthcare Conference on Monday, June 6, 2011, at 3:00 p.m. ET in New York City. In addition, Alkermes’ corporate presentation will be webcast live from the Goldman Sachs 32nd Annual Global Healthcare Conference on Tuesday, June 7, 2011, at 5:10 p.m. ET (2:10 p.m. PT) in Rancho Palos Verdes, Calif. The presentations may be accessed under the investor relations tab at www.alkermes.com. The presentations will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.
Eva Stroynowski, 781-609-6823
KEYWORDS: United States North America California Massachusetts New York
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical